pharma news today obesity drugs glp-1 october 2025 The outlook for from 2026 to 2030 GLP-1 Market Trends and Global

6 As evidenced by these findings, data regarding the effectiveness of oral glutathione in raising plasma levels is limited and controversial

Common GLP-1 agonists include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Zepbound) While initially used for diabetes management, studies showed that GLP-1 agonists also contribute significantly to weight loss, leading to their approval for obesity treatment as well

[51] showed that chondrocyte lipid peroxidation may contribute to cartilage aging and OA

Ayuda, tambin, a proteger las clulas del dao oxidativo, lo que puede reducir el riesgo de enfermedades crnicas como el cncer, las enfermedades cardacas y el envejecimiento prematuro

doi: 10.1210/jc.2006-1821 59 YuLZhouLXuEBiYHuXPeiXet al